Thurston Springer Miller Herd & Titak’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,000
Closed -$161K 766
2025
Q2
$161K Hold
10,000
0.02% 404
2025
Q1
$158K Buy
+10,000
New +$165K 0.03% 367

Other funds holding ECAT

Thurston Springer Miller Herd & Titak's ECAT Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q3 2025, closing a stake of 10,000 shares — an estimated $161K sold.

Thurston Springer Miller Herd & Titak first reported a position in ECAT in Q1 2025 and held it in 2 quarters. The position peaked at $161K in Q2 2025. 74 funds tracked by Wall St. Rank hold ECAT as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 10,000 BlackRock ESG Capital Allocation Term Trust shares in Q3 2025, an estimated $161K.
  • Thurston Springer Miller Herd & Titak first reported a position in BlackRock ESG Capital Allocation Term Trust in Q1 2025 and held it in 2 quarters.
  • Thurston Springer Miller Herd & Titak's BlackRock ESG Capital Allocation Term Trust position peaked at $161K in Q2 2025.
  • 74 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.